Dupont Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-23,200
| Closed | -$3.99M | – | 2060 |
|
|
2021
Q3 | $3.99M | Buy |
+23,200
| New | +$3.99M | 0.13% | 151 |
|
|
2018
Q3 | – | Sell |
-15,488
| Closed | -$751K | – | 1052 |
|
|
2018
Q2 | $751K | Buy |
15,488
+10,677
| +222% | +$518K | 0.02% | 614 |
|
|
2018
Q1 | $188K | Buy |
+4,811
| New | +$188K | ﹤0.01% | 817 |
|
|
2017
Q2 | – | Sell |
-12,037
| Closed | -$319K | – | 1012 |
|
|
2017
Q1 | $319K | Hold |
12,037
| – | – | 0.01% | 780 |
|
|
2016
Q4 | $307K | Sell |
12,037
-5,313
| -31% | -$136K | 0.01% | 770 |
|
|
2016
Q3 | $628K | Hold |
17,350
| – | – | 0.01% | 538 |
|
|
2016
Q2 | $590K | Buy |
+17,350
| New | +$590K | 0.01% | 554 |
|